Plasma clearance (CLp) values for ten additional compounds from

Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net Reabsorption

Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats

Frontiers Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential

Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B KATP Channels

Antioxidants, Free Full-Text

IJMS, Free Full-Text

Ligand binding: ratio of experimental f u to true f u in relation to P

Toxins, Free Full-Text

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

Epigenetic mechanisms of Immune remodeling in sepsis: targeting histone modification

Frank BYERS, Research Assistant, Vanderbilt University, TN, Vander Bilt, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD)

Marine Drugs, Free Full-Text

Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19

PDF) Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria